White Papers and Resources
Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.
Navigating NHS Market Access: Policy Change and Opportunity in England
August 19, 2025 | White Papers and Resources |
With the changes at NHS England and the publishing of the 10-Year Plan, there is a lot of talk of change in the NHS in …
Brought to you by Petauri Evidence
Implementation of Cost-Effectiveness Analysis in Japan’s Health Technology Assessment Process
August 6, 2025 | White Papers and Resources |
Japan’s evolving approach to market access includes a formal cost-effectiveness analysis (CEA) requirement for certain new medicines and medical devices. Introduced as part of a …
Brought to you by Petauri Evidence
Digital Transformation in the NHS’s 10-Year Plan: Techno-Optimism and the Limits of Efficiency
July 29, 2025 | White Papers and Resources |
Here, Evelyne Priestman (Senior Consultant – HEOR) and Mary Baker (Senior Medical Writer) at Petauri Evidence explore the National Health Service (NHS) in England’s newly …
Brought to you by Petauri Evidence
US Payer Panel Insights Survey: Evolving Evidence Landscape and Priorities
July 22, 2025 | White Papers and Resources |
Download the first edition of the Petauri ‘US Payer Panel Insights Survey: Evolving Evidence Landscape and Priorities’ report
Brought to you by Petauri Evidence
Insights From ISPOR 2025: Breaking the Data Barrier in Rare Diseases – Can AI Bridge the Gap?
June 17, 2025 | White Papers and Resources |
Last month, the ISPOR annual meeting in Montreal was brimming with opportunities to explore the latest developments and insights in health economics and outcomes research …
Brought to you by Petauri Evidence
Sustainability and Environmental Impact in Market Access and Health Economics
June 10, 2025 | White Papers and Resources |
As the concept of sustainability gains traction in healthcare, it is beginning to influence how value is assessed and communicated across the Pharmaceutical and Medtech …
Brought to you by Petauri Evidence
Insights From ISPOR 2025: R In Health Technology Assessment – Is It The Future?
June 3, 2025 | White Papers and Resources |
ISPOR’s annual meeting in Montreal this May was packed with opportunities to explore the latest trends, insights, and research in HEOR and market access. In …
Brought to you by Petauri Evidence
The abolition of NHS England: Navigating NHS restructuring and its impact on the pharmaceutical industry
March 18, 2025 | White Papers and Resources |
Last week Prime Minister Sir Keir Starmer announced the abolition of NHS England to “cut bureaucracy” and bring management of the health service “back into …
Brought to you by Petauri Evidence
Navigating market access: Launch strategies and health economic modelling for medical devices – a live panel discussion
March 4, 2025 | White Papers and Resources |
Discover how health economics can support successful Medical Device launch, proposition development, and market access. Join us live at 1:30pm (GMT) on Wednesday 19th March …
Brought to you by Petauri Evidence
Your essential guide to the World EPA Congress 2025: Top sessions and pre-reading
February 18, 2025 | White Papers and Resources |
The World EPA organisers have curated an exceptional programme featuring thought-provoking presentations and dynamic panel sessions led by industry leaders driving market access strategy and …
Brought to you by Petauri Evidence